| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA700561 | F | cytotoxicity against leukemia subpanel (K562) | Homo sapiens | 1 | ALA1128257 | cell-based format | Scientific Literature | |
| 2. | ALA700562 | F | cytotoxicity against leukemia subpanel (K562); Experiment 1 | Homo sapiens | 1 | ALA1128257 | cell-based format | Scientific Literature | |
| 3. | ALA701198 | F | cytotoxicity against leukemia subpanel (K562); Experiment 2 | Homo sapiens | 1 | ALA1128257 | cell-based format | Scientific Literature | |
| 4. | ALA858462 | F | Tested in vitro for cytotoxicity in K-562 cell line of Leukemia | Homo sapiens | 1 | ALA1127574 | cell-based format | Scientific Literature | |
| 5. | ALA701199 | F | Tested in vitro for cytotoxicity in K-562 cell line of Leukemia | Homo sapiens | 1 | ALA1127574 | cell-based format | Scientific Literature | |
| 6. | ALA701200 | F | In vitro activity of compound against leukemia K-562 cell line | Homo sapiens | 1 | ALA1128550 | cell-based format | Scientific Literature | |
| 7. | ALA701201 | F | Cytotoxicity against mouse K-562 leukemic cell line, by means of standard proliferation assay | Mus musculus | 9 | ALA1132377 | cell-based format | Scientific Literature | |
| 8. | ALA701202 | F | In vitro inhibition of leukemia K-562 cell line. | Homo sapiens | 1 | ALA1126183 | cell-based format | Scientific Literature | |
| 9. | ALA701203 | F | In vitro inhibition of leukemia K-562 cell line | Homo sapiens | 1 | ALA1126183 | cell-based format | Scientific Literature | |
| 10. | ALA701204 | F | Cytostatic activity against chronic myelogenous leukemia cells (K-562) based on its ability to inhibit [3H]thymidine incorporation | Homo sapiens | 10 | ALA1135898 | cell-based format | Scientific Literature | |
| 11. | ALA701205 | F | Cytostatic activity against chronic myelogenous leukemia cells (K-562) based on its ability to inhibit [3H]thymidine incorporation (at 1.0 g/ml) | Homo sapiens | 2 | ALA1135898 | cell-based format | Scientific Literature | |
| 12. | ALA701206 | F | Cytostatic activity against chronic myelogenous leukemia cells (K-562) based on its ability to inhibit [3H]thymidine incorporation. | Homo sapiens | 5 | ALA1135898 | cell-based format | Scientific Literature | |
| 13. | ALA701207 | F | Cytostatic activity against chronic myelogenous leukemia cells (K-562) based on its ability to inhibit [3H]thymidine incorporation; ND means not determined. | Homo sapiens | 3 | ALA1135898 | cell-based format | Scientific Literature | |
| 14. | ALA701208 | F | Concentration of compound that cause 50% cytotoxicity of K-562 leukemia cell line | Homo sapiens | 1 | ALA1145965 | cell-based format | Scientific Literature | |
| 15. | ALA701209 | F | In vitro anticancer activity against K-562 leukemia cell line | Homo sapiens | 1 | ALA1152086 | cell-based format | Scientific Literature | |
| 16. | ALA701210 | F | Cytotoxicity against NCI tumor panel, K-562 leukemia cell line | Homo sapiens | 1 | ALA1133719 | cell-based format | Scientific Literature | |
| 17. | ALA701211 | F | In vitro cytotoxicity was determined against K-562 human leukemia cell line using NCI screen | Homo sapiens | 1 | ALA1124780 | cell-based format | Scientific Literature | |
| 18. | ALA701212 | F | Antitumor activity against K-562 leukemia cell line | Homo sapiens | 4 | ALA1127500 | cell-based format | Scientific Literature | |
| 19. | ALA701979 | F | Cytotoxicity against cell line K562 determined by MTT test | Homo sapiens | 3 | ALA1135662 | cell-based format | Scientific Literature | |
| 20. | ALA701980 | F | Dose required to inhibit cell growth was determined against K562 cell line of chronic myelogenous leukemia | Homo sapiens | 39 | ALA1134792 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!